Crossject nomme Dan Chiche, MD au poste de Directeur Médical Amérique du Nord
12 juin 2024 01h30 HE
|
CROSSJECT
Dr Chiche mettra à profit sa vaste expérience en matière de développement de médicaments aux États-Unis et à l'international et de valorisation de produits médicaux ;Renforcera l'équipe dirigeante...
Crossject appoints Dan Chiche, MD as Chief Medical Officer North America
12 juin 2024 01h30 HE
|
CROSSJECT
Brings extensive experience in drug development in the U.S and internationally and in maximizing value of medical productsReinforces leadership team and expands presence in North AmericaSupports...
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts
25 avr. 2024 07h00 HE
|
Nucleome Therapeutics
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts John Davis brings direct clinical expertise as...
Raphael Bres Returns to Tradeshift as Chief Product & Technology Officer
04 avr. 2024 08h23 HE
|
Tradeshift
San Francisco, April 04, 2024 (GLOBE NEWSWIRE) -- Tradeshift, the B2B e-commerce and fintech platform, today announces Raphael Bres has rejoined the company as Chief Product & Technology Officer...
TrueCommerce Bolsters Global Customer Support with Executive Appointment
12 déc. 2023 08h00 HE
|
TrueCommerce
TrueCommerce appoints Amy Harvey as head of global support to lead the global customer support strategy and teams across regions.
20Med Therapeutics Appoints Industry Veteran Hugo Fry as Chief Business Officer to Expedite mRNA Vaccine Delivery Platform Program
29 nov. 2023 03h00 HE
|
20MED Therapeutics B.V.
Leiden, The Netherlands, November 29, 2023 – 20Med Therapeutics, a leader in non-viral delivery of mRNA vaccines, today announced the appointment of Hugo Fry as Chief Business Officer. His appointment...
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
19 oct. 2023 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...
Myricx Expands its Leadership Team with the Appointment of Dr. Robert McLeod as VP Clinical Development
13 sept. 2023 04h00 HE
|
Myricx Bio
LONDON, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery and development of a completely novel class of selective cytotoxic payloads for...
BC Platforms Appoints Mikaela Bruhammar as Chief Operating Officer, Markets
12 sept. 2023 06h00 HE
|
BC Platforms
ZURICH, Switzerland, Sept. 12, 2023 (GLOBE NEWSWIRE) -- BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the appointment of Mikaela Bruhammar, an...
Discovery Announces Key Appointments to the Board and Management Team
24 août 2023 06h00 HE
|
Discovery Silver Corp.
TORONTO, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) is pleased to announce several key appointments that strengthen the...